D Bruttomesso, S Costa, A Baritussio - Diabetes Metab. Res. Rev. 2009 26; 25 (2): 99 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 2 versions
S Goykhman, A Drincic, JC Desmangles, M … - Expert Opin. Pharmacother., 2009 - informahealthcare.com Insulin Glargine was the first long-acting insulin analog produced by
recombinant DNA technology, approved for use by the US FDA in April 2000 and by
the European Agency for the Evaluation of Medicinal Products in June, 2000. ... Cited by 2 - Related articles - All 5 versions
A Pfützner, T Asakura, B Sommavilla, WC Lee - Expert Opin. Drug Deliv., 2008 - informahealthcare.com The introduction of insulin pens has helped improve adherence in Type 1 or 2
diabetes, and reduce inaccurate dosing, fear of injection, and social
embarrassment associated with vial and syringe. This report presents the ... Cited by 3 - Related articles - All 6 versions
P Hammond - The British Journal of Diabetes & Vascular Disease, 2008 - dvd.sagepub.com Page 1. http://dvd.sagepub.com Disease The British Journal of Diabetes &
Vascular DOI: 10.1177/1474651408097726 2008; 8; S11 British ... Cited by 1 - Related articles - All 3 versions
MJ Fowler - Clinical Diabetes, 2008 - Am Diabetes Assoc Hypoglycemia is in many ways the Achilles' heel of diabetes treatment. Medical
authors have astutely noted that hypoglycemia is “the limiting factor” in
the treatment of diabetes. 1-3 Reduction of glucose levels in patients with ... Related articles - All 2 versions
[CITATION] Conjugation of ATIII-Binding Pentasaccharides to Extend the Half-Life of Proteins: Long- …
M de  Kort, B Gianotten, JAJ Wisse, … - ChemMedChem, 2008 - WILEY-VCH Verlag Weinheim Related articles
K Kumareswaran, ML Evans, R Hovorka - Expert Review of Medical Devices, 2009 - ingentaconnect.com Types of diabetes There are two main forms of diabetes: Type 1 and Type 2, the
latter accounting for up to 95% of cases. Type 1 diabetes results from auto-
immune destruction of the insulin-producing b-cells in the pancreatic ... Related articles - All 4 versions
AC Powers - Nature Clinical Practice Endocrinology & Metabolism, 2008 - nature.com Alvin C Powers received his undergraduate degree from the University of Virginia
and his medical degree from the University of Tennessee Center for the Health
Sciences. After training in internal medicine at Duke University Medical ... Cited by 1 - Related articles - All 3 versions
AC Wiseman - Advances in Chronic Kidney Disease, 2009 - Elsevier Advances in technical aspects of pancreas transplantation and improvements in
immunosuppression over the last decade have led to significant improvements in
pancreas transplant outcomes in the short-term. Simultaneous kidney ... Related articles - All 15 versions
G Scheiner, RJ Sobel, DE Smith, AJ Pick, D … - The Diabetes Educator, 2009 - tde.sagepub.com Current forms of insulin delivery used in the treatment of diabetes mellitus
(diabetes) include syringes, pens, and insulin pumps. Technical advantages of
insulin pump therapy, or continuous subcutaneous insulin delivery (CSII), ... Related articles - All 3 versions
